171 related articles for article (PubMed ID: 19883307)
1. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.
Kohrt H; Advani R
Leuk Lymphoma; 2009 Nov; 50(11):1773-84. PubMed ID: 19883307
[TBL] [Abstract][Full Text] [Related]
2. Misdiagnosed Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Successfully Treated: A Case Report.
Saavedra Ramírez JD
Case Rep Oncol; 2017; 10(3):948-953. PubMed ID: 29279697
[TBL] [Abstract][Full Text] [Related]
3. Types of T-cell lymphoma-a cytogenetic perspective.
Samad MA; Mahboob E; Shafiq A; Ur Rehman MH; Sheikh A; Tharwani ZH
Ann Med Surg (Lond); 2022 Dec; 84():104844. PubMed ID: 36536747
[TBL] [Abstract][Full Text] [Related]
4. Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.
Li DM; Lun L
Front Med (Lausanne); 2022; 9():851208. PubMed ID: 35783622
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia.
Yoon SE; Song Y; Kim SJ; Yoon DH; Chen TY; Koh Y; Kang KW; Lee HS; Tay KKW; Lim ST; Poon M; Irawan C; Zhao W; Do YR; Lee MH; Ng SC; Lee WS; Guo Y; Zhang H; Kang HJ; Yun HJ; Kim HJ; Lung DTC; Kwak JY; Han JJ; Mun YC; Oh SY; Shim H; Kwon JH; Sohn BS; Park SK; Jo JC; Ko YH; Jun Z; Kim WS
Lancet Reg Health West Pac; 2021 May; 10():100126. PubMed ID: 34327343
[TBL] [Abstract][Full Text] [Related]
6. Case Report:
Li DM; Lun L; Ge J; Zhang GJ; Li XL; de Hoog GS
Front Med (Lausanne); 2021; 8():578684. PubMed ID: 34150783
[No Abstract] [Full Text] [Related]
7. Extra-Nodal, Nasal, Natural Killer T-Cell Lymphoma Treated With a Checkpoint Inhibitor: A Case Report of a Sustained Complete Response.
Diab R; Kamran S; Adcock B; Choucair K; Truong QV
Cureus; 2021 Apr; 13(4):e14654. PubMed ID: 34046285
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
[TBL] [Abstract][Full Text] [Related]
9. Primary Gastrointestinal Involvement in a Case of Extranodal-Extranasal Natural Killer T Cell Lymphoma.
Lookzadeh S; Pourabdollah Toutkaboni M; Jamaati H; Rezaei M; Marashian M
Tanaffos; 2020 Jan; 19(1):74-78. PubMed ID: 33101435
[TBL] [Abstract][Full Text] [Related]
10. F-18 Fluorodeoxyglucose Positron-Emission Tomography-Computed Tomography in a Case of Extensive Multi-Organal Extranodal Lymphoma with Cardiac Involvement Mimicking Apical Hypertrophic Obstructive Cardiomyopathy: Staging and Response Evaluation.
Vadi SK; Parihar AS; Mittal BR; Kumar R; Singh H; Malhotra P
Indian J Nucl Med; 2018; 33(4):370-373. PubMed ID: 30386069
[TBL] [Abstract][Full Text] [Related]
11. Specific Soft-Tissue Invasion and LMP1 Expression Are Potential Indicators of Extranodal NK/T Cell Lymphoma, Nasal Type.
Jiang M; Lu H; Lu C; Geng X; Jia Y; Wang P; Qian W; Huang H; Shan X
Med Sci Monit; 2018 Oct; 24():7603-7613. PubMed ID: 30356034
[TBL] [Abstract][Full Text] [Related]
12. PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
Zheng W; Gao Y; Ke X; Zhang W; Su L; Ren H; Lin N; Xie Y; Tu M; Liu W; Ping L; Ying Z; Zhang C; Deng L; Wang X; Song Y; Zhu J
BMC Cancer; 2018 Sep; 18(1):910. PubMed ID: 30241515
[TBL] [Abstract][Full Text] [Related]
13. Primary pulmonary extranodal NK/T-cell lymphoma of nasal type misdiagnosed as pneumonia: A case report and literature review.
Zhang J; Wang M; Yang X; Liu C; He X
Medicine (Baltimore); 2017 Dec; 96(49):e8914. PubMed ID: 29245256
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram.
Cao J; Lan S; Shen L; Si H; Xiao H; Yuan Q; Li X; Li H; Guo R
Sci Rep; 2017 Sep; 7(1):10982. PubMed ID: 28887511
[TBL] [Abstract][Full Text] [Related]
15. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R
Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491
[TBL] [Abstract][Full Text] [Related]
16. Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapy.
Laudien M
GMS Curr Top Otorhinolaryngol Head Neck Surg; 2015; 14():Doc04. PubMed ID: 26770278
[TBL] [Abstract][Full Text] [Related]
17. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.
Lima M
Orphanet J Rare Dis; 2013 Jul; 8():95. PubMed ID: 23816348
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy in untreated patients improves outcome in nasal NK/T lymphoma: results of a clinical trial.
Avilés A; Neri N; Fernández R; Huerta-Guzmán J; Nambo MJ
Med Oncol; 2013; 30(3):637. PubMed ID: 23797771
[TBL] [Abstract][Full Text] [Related]
19. Reconstruction of a rare palate defect originating from extranodal natural killer/t-cell lymphoma.
Han SE; Lim SY
Arch Plast Surg; 2013 May; 40(3):291-4. PubMed ID: 23730618
[No Abstract] [Full Text] [Related]
20. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.
Kim CY; Hong CM; Kim DH; Son SH; Jeong SY; Lee SW; Lee J; Ahn BC
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1321-9. PubMed ID: 23674211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
